about
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosisGenome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patientsVariants within the immunoregulatory CBLB gene are associated with multiple sclerosisRare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia.mtDNA nt13708A variant increases the risk of multiple sclerosis.Lymphocyte subsets at different stages of subacute sclerosing panencephalitis: a study with monoclonal antibodies.Three years of experience: the Italian registry and safety data update.Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype?Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidityThe Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles.Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.Genetic architecture of ALS in SardiniaStructural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation studyInteraction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosisVariation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia.Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.What do multiple sclerosis patients and their caregivers perceive as unmet needs?A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTDClinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patientsC9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations.Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations.Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonismsEfficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations.
P50
Q26852672-444688D3-68DE-464E-92B9-3FFD3AF31E8CQ28730143-98EC3070-FA6C-40FB-9745-BF252534C243Q28741088-7CAC6237-512F-4D77-A71D-ECB56BC34776Q28943396-DFCA8E27-5EF2-4A09-B112-F0DE38B0AD93Q30426245-6E146714-496A-43C1-A90B-C5FDB3923C48Q30653549-09DD2930-264C-42F5-BA15-66F864F508B6Q31162052-9FC85D85-6819-4C26-9316-FB7318A7F894Q33284956-51290A87-9F55-46E4-BB9E-ACE4255E9990Q33315480-38DB1B49-56BA-49A5-9B92-4D9579E1808AQ33319550-7B098728-3AE8-425E-9959-FE08B7ABC0EEQ33622373-A3014689-5194-4DB2-9053-A09D5F9E397BQ33636476-4B914B69-DF47-4E82-8985-005873503095Q34180936-6F0207B9-7AB3-415D-99DA-C97AA22EE04EQ34187215-AC51AFDC-90D0-460E-AA58-1E0A65D409B5Q34234374-15CFBEE3-FC10-4D61-992A-9C22128C23D0Q34235080-134D03F0-4A88-4996-A8D3-39FFE9B6100AQ34296780-D2209DC1-3B3A-4B46-B848-C5E6A11B2451Q34358801-D5E59E94-994B-4897-9F17-7A9B989FCF58Q34527935-940B495B-4CF6-4868-B640-4E03FCBB6C50Q34592143-58B96363-A69A-4879-960E-B6E90AF38B19Q34613626-03C5D68F-4804-4ADE-8317-BA2CD353119EQ34651994-4AA0DE2B-1F35-4A09-B83D-0A405D2BFE8AQ34672509-4E81852E-CA36-4F51-BE28-ADE494900ECBQ34807095-7E54CF4D-3F58-4F8C-8795-3DDC954791F1Q34863892-EB6A3FF6-BF0F-4717-9A54-36AA05C4885FQ35007562-302CED29-85B9-4360-A469-FAC1827F2D86Q35044227-F406D527-E9B3-4B1D-9F06-CE48CEDCA6F7Q35332219-DE773A0E-259E-4878-978C-204815DE63F1Q35776923-0E32692B-E6F1-45FE-9CB7-2A10A43A6160Q35809567-8D4B9115-EE8F-4B3D-ADB9-CB8A25F1A856Q36024669-2E9848AE-99D7-4D2C-ADA0-CF923865B7BCQ36057290-BFC7BF64-DF70-43BD-BD5F-8880E9688AA4Q36367612-4DA93BF0-081E-481A-9B51-862E8ED5BAA2Q36441637-E61A99D8-184A-4741-8068-FB47B4753948Q36504551-E863D1A3-877D-4F3A-A58E-8A31A76FC102Q36666373-7517B231-B664-490E-AB58-33D7D95014A9Q36865769-9972BFBB-7443-4895-AD4C-3760F3BBA189Q37235845-995CEF89-C094-4075-96BF-802B638B8950Q37540488-CA81CAE4-37F8-4A76-8E0B-828CA1B204C4Q38085610-DF17446A-4ECE-4ECF-8925-2AC595E14AF7
P50
description
Italiaans onderzoekster
@nl
Italian researcher
@en
scienziata e neurologa italiana
@it
taighdeoir Iodálach
@ga
name
Maria Giovanna Marrosu
@ast
Maria Giovanna Marrosu
@en
Maria Giovanna Marrosu
@es
Maria Giovanna Marrosu
@ga
Maria Giovanna Marrosu
@it
Maria Giovanna Marrosu
@nl
Maria Giovanna Marrosu
@sl
Maria Giovanna Marrosu
@sq
type
label
Maria Giovanna Marrosu
@ast
Maria Giovanna Marrosu
@en
Maria Giovanna Marrosu
@es
Maria Giovanna Marrosu
@ga
Maria Giovanna Marrosu
@it
Maria Giovanna Marrosu
@nl
Maria Giovanna Marrosu
@sl
Maria Giovanna Marrosu
@sq
prefLabel
Maria Giovanna Marrosu
@ast
Maria Giovanna Marrosu
@en
Maria Giovanna Marrosu
@es
Maria Giovanna Marrosu
@ga
Maria Giovanna Marrosu
@it
Maria Giovanna Marrosu
@nl
Maria Giovanna Marrosu
@sl
Maria Giovanna Marrosu
@sq
P1153
7006500728
P21
P27
P31
P4012
P496
0000-0003-2334-2081